tiprankstipranks
Trending News
More News >

Keith Katkin Insider Profile

4 Followers
Keith Katkin, President & CEO, Director at Avanir Pharmaceuticals, holds 90.00K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 59.87K shares in Emergent Biosolutions (Ticker: EBS), holds 25.00K shares in Rigel (Ticker: RIGL).
tipranks
Keith Katkin

Keith Katkin
Avanir Pharmaceuticals (AVNR)
President & CEO, Director

Not Ranked
Keith Katkin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
57.18%
24.29%
16.36%
2.17%
0.00% Others
A breakdown of Keith Katkin's holdings

Insider Roles

Syndax Pharmaceuticals
(SNDX)
Director
Rigel
(RIGL)
Director
Emergent Biosolutions
(EBS)
Director
Eledon Pharmaceuticals
(ELDN)
Director
+1 other positions
Roles that Keith Katkin holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Keith Katkin

Keith Katkin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AVNR
Avanir Pharmaceuticals
Dec 17, 2014
Uninformative Sell
4.71M
Syndax Pharmaceuticals
Feb 07, 2025
Director
Uninformative Buy
$1.21M
Eledon Pharmaceuticals
May 11, 2017
Director
Uninformative Buy
$45.93K
UROV
Urovant Sciences
Jan 09, 2020
Uninformative Buy
$3.24M
Emergent Biosolutions
May 28, 2024
Director
Uninformative Buy
$345.46K
Rigel
May 21, 2021
Director
Uninformative Buy
$513.00K
KalVista Pharmaceuticals
Director
$0.00
List of latest transactions for each holding click on a transaction to see Keith Katkin's performance on stock

Keith Katkin insider profile FAQ

What is the percentage of profitable transactions made by Keith Katkin?
The percentage of profitable transactions made by Keith Katkin is ―.
    What is the average return per transaction made by Keith Katkin?
    The average return per transaction made by Keith Katkin is ―.
      What stocks does Keith Katkin hold?
      Keith Katkin holds: AVNR, SNDX, ELDN, UROV, EBS, RIGL, KALV stocks.
        What was Keith Katkin’s latest transaction?
        Keith Katkin latest transaction was an Uninformative Buy of ―.
          What was Keith Katkin's most profitable transaction?
          Keith Katkin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Keith Katkin's role in Avanir Pharmaceuticals?
            Keith Katkin's role in Avanir Pharmaceuticals is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.